Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 968667Erstellt: 23. Oktober 2026

m-Chloroperbenzoic acid → N-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4methoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-amine

https://huagongshe.com/de/reaction/968667

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Eduktm-Chloroperbenzoic acidHCID 70297—
EduktPotassium FluorideHCID 522689—
Edukt2-(Methylthio)-4-(tributylstannyl)pyrimidineHCID 2763261—
EduktN-cyclopentyl-2-(4-methoxyphenyl)-3-[2-(methylsulfanyl)pyrimidin-4yl]pyrazolo[1,5-a]pyrimidin-7-amineHCID 69489940—
EduktN-cyclopentyl-3-iodo-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-amineHCID 69490015—
EduktN-cyclopentyl-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-amineHCID 69491756—
KatalysatorHCID 178418476HCID 178418476—
LösungsmittelTolueneHCID 1140—
LösungsmittelDichloromethaneHCID 6344—
LösungsmittelEthyl AcetateHCID 8857—
ProduktN-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4methoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-amineHCID 4548564811%

Reaktionsbedingungen

Temperatur110 °C

Reaktionsschritte

N-Cyclopentyl-3-iodo-2-(4-methoxyphenyl)pyrazolo[1,5-α]pyrimidin-7-amine (63 mg, 0.15 mmol), dichlorobis(triphenylphosphine)palladium(II) (25 mg, 0.015 mmol), and 2-(methylsulfanyl)-4-(tributylstannyl)pyrimidine (78 mg, 0.19 mmol) were added to toluene (3 mL) and heated to 110° C. for 16 hours. Additional dichlorobis(triphenylphosphine)palladium(II) (6 mg) was added and the reaction heated to 110° C. for 24 hours. The reaction was allowed to cool to room temperature, diluted with ethyl acetate, poured into 10% aqueous potassium fluoride containing 1% methanol, and stirred for 20 minutes before being extracted with ethyl acetate. The organic phase was concentrated and the residue purified by silica chromatography, eluting with a gradient of 5% to 10% acetone in dichloromethane to yield 25 mg of an approximate 1:1 mixture of N-cyclopentyl-2-(4-methoxyphenyl)pyrazolo[1,5-α]pyrimidin-7-amine and N-cyclopentyl-2-(4-methoxyphenyl)-3-[2-(methylsulfanyl)pyrimidin-4yl]pyrazolo[1,5-α]pyrimidin-7-amine. To a 0° C. solution of this mixture in dichloromethane (1 mL) was added 3-chloroperoxybenzoic acid (0.099 mg, 0.058 mmol). The mixture was allowed to warm to room temperature and stirred for 2 hours. The mixture was diluted with dichloromethane, washed with saturated aqueous sodium bicarbonate, and concentrated. The residue was dissolved in cyclopentylamine and stirred at room temperature for 2.5 hours. The mixture was concentrated and the residue purified by silica chromatography, eluting with a gradient of 5% to 15% acetone in dichloromethane to yield 14 mg (11%) of N-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4methoxyphenyl)pyrazolo[1,5-α]pyrimidin-7-amine. 1H NMR (CDCl3):δ 8.37 (d, 1H), 8.26 (d, 1H), 7.67 (d, 2H), 6.99 (d, 2H), 6.50 (d, 1H), 6.11 (d, 1H), 5.01 (m, 1H), 4.09 (m, 1H), 3.90 (s, 3H), 2.20 (m, 2H), 1.75 (m, 14H); MS m/z 470 (M+1).

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS07304068B2
Quelldatensatzuspto-grants-2007_12
ORD IDord-faadbae44cda4e9fbb1d20e28d49c886
Quellennotizuspto-grants-2007_12